Cl.[C:2]1([C:8]2[CH:9]=[N:10][NH:11][CH:12]=2)[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.CCN(C(C)C)C(C)C.Cl[C:23](Cl)([O:25]C(=O)OC(Cl)(Cl)Cl)Cl.Cl.[NH2:35][CH2:36][C:37]([N:39]1[CH2:44][CH2:43][N:42]([C:45](=[O:56])[C:46]2[CH:51]=[CH:50][CH:49]=[CH:48][C:47]=2[C:52]([F:55])([F:54])[F:53])[CH2:41][CH2:40]1)=[O:38]>C(Cl)Cl.O>[O:38]=[C:37]([N:39]1[CH2:40][CH2:41][N:42]([C:45](=[O:56])[C:46]2[CH:51]=[CH:50][CH:49]=[CH:48][C:47]=2[C:52]([F:55])([F:53])[F:54])[CH2:43][CH2:44]1)[CH2:36][NH:35][C:23]([N:10]1[CH:9]=[C:8]([C:2]2[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=2)[CH:12]=[N:11]1)=[O:25]A mixture of 4-Phenyl-1H-pyrazole hydrochloride salt (prepared by the method described above)(44 mg, 0.3 mmol), DIPEA (88 mg, 0.119 ml, 0.685 mmol) and DCM (2 ml) was added to a stirred solution of triphosgene (36 mg, 0.12 mmol) in DCM (1 mL) at room temperature. After 30 minutes, to the above solution, a mixture of 2-amino-1-[4-(2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethanone hydrochloride salt (prepared by the method described above)(108 mg, 0.3 mmol), DIPEA (88 mg, 0.119 ml, 0.685 mmol) and DCM (2 ml) was added and the resulting mixture was stirred at room temperature for 30 minutes. Cold water was then added and the product was extracted with EtOAc and the organic layer was washed with brine. The organic phase was dried over Na2SO4 and concentrated under reduced pressure to get the residue. The obtained residue was purified by column chromatography (using silica gel of 60-120 mesh and 30-70% EtOAc in Hexane as eluent) to afford 48.8 mg (32.97% yield) 4-Phenyl-pyrazole-1-carboxylic acid {2-oxo-2-[4-(2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethyl}-amide. LCMS Purity: 97.25%. 1H NMR (CDCl3): δ 8.48-8.4 (d, 1H), 8.04-7.98 (bs, 1H), 7.96-7.92 (s, 1H), 7.8-7.74 (d, 1H), 7.7-7.58 (m, 2H), 7.56-7.5 (d, 2H), 7.44-7.1 (m, 4H), 4.38-4.3 (d, 2H), 4.28-4.2 (t, 1H), 4.1-4.0 (bs, 1H), 3.82-3.66 (m, 2H), 3.64-3.5 (m, 2H), 3.46-3.38 (t, 1H),), 3.32-3.2 (s, 2H).
불러오는 중…